Ayares; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ayares; David.The latest application filed is for "compositions and methods for preventing allergies".

Company Profile

3.10.18

Ayares; David - Blacksburg VA
Ayares, David - Blacksburgh VA
Ayares, David - Lindenhurst IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Preventing Allergies App 20220257829 - Bianchi; John ; et al.	2022-08-18
Multi-transgenic Pigs With Growth Hormone Receptor Knockout For Xenotransplantation App 20220211018 - ROTHBLATT; Martine ; et al.	2022-07-07
Genetically Modified Pigs For Xenotransplantation Of Vascularized Xenografts And Derivatives Thereof App 20220072200 - AYARES; David	2022-03-10
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof Grant 11,179,496 - Ayares November 23, 2	2021-11-23
Ungulates with genetically modified immune systems Grant 11,085,054 - Wells , et al. August 10, 2	2021-08-10
Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase Grant 10,912,863 - Ayares , et al. February 9, 2	2021-02-09
Ungulates with Genetically Modified Immune Systems App 20200109415 - Wells; Kevin ; et al.	2020-04-09
Tissue Products Derived from Animals Lacking any Expression of Functional Alpha 1, 3 Galactosyltransferase App 20190111180 - Ayares; David ; et al.	2019-04-18
Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase Grant 10,130,737 - Ayares , et al. November 20, 2	2018-11-20
Ungulates with Genetically Modified Immune Systems App 20170183685 - Wells; Kevin ; et al.	2017-06-29
Ungulates with genetically modified immune systems Grant 9,585,374 - Wells , et al. March 7, 2	2017-03-07
Multi-transgenic pigs for diabetes treatment Grant 9,339,519 - Ayares May 17, 2	2016-05-17
Tissue Products Derived from Animals Lacking any Expression of Functional Alpha 1, 3 Galactosyltransferase App 20150182664 - Ayares; David ; et al.	2015-07-02
Genetically Modified Pigs for Xenotransplantation of Vascularized Xenografts and Derivatives Thereof App 20140017215 - Ayares; David	2014-01-16
Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase App 20120282226 - Ayares; David ; et al.	2012-11-08
Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase Grant 8,106,251 - Ayares , et al. January 31, 2	2012-01-31
Multi-Transgenic Pigs for Diabetes Treatment App 20110038841 - Ayares; David	2011-02-17
Ungulates with Genetically Modified Immune Systems App 20100077494 - Wells; Kevin ; et al.	2010-03-25
Ungulates with genetically modified immune systems App 20080026457 - Wells; Kevin ; et al.	2008-01-31
Ungulates with genetically modified immune systems App 20060130157 - Wells; Kevin ; et al.	2006-06-15
Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase App 20050260176 - Ayares, David ; et al.	2005-11-24
Mini-Ad vector for immunization App 20040208846 - Zhang, Wei-Wei ; et al.	2004-10-21
Minimal adenoviral vector App 20030192066 - Zhang, Wei-Wei ; et al.	2003-10-09
Adenovirus E1-complementing cell lines App 20010046965 - Ayares, David ; et al.	2001-11-29

Company Registrations

NCAGE Code	3S1J4	AYARES DAVID
CAGE Code	3S1J4	AYARES, DAVID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.